Crystal Phend is a Contributing Editor at MedPage Today. She covers a range of topics including the Coronavirus, data analysis, FDA developments, nutrition, and issues relevant to the Hispanic community. Her work has been featured in various reputable publications, highlighting her expertise in these critical areas.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
Decision cites insufficient evidence of clinical meaningfulness
GUIDE-HF trial analysis distinguishes risk 'strata' with different levels of benefit
Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial
STRONG-HF analysis details the impact
By: Crystal Phend
Early-phase study analysis suggests potential for remodeling
Splanchnic nerve ablation for volume management passes a feasibility hurdle
The first randomized trials of both approaches failed
By: Crystal Phend
DISCOMS trial has provided data to guide decisions, now it's all about individualized discussions
PROTECT trial may expand the biologic's use into a larger pool of recently diagnosed patients
Strategies for decongestion, inotropic support, and optimizing guideline-directed medical therapy
(833) 317-6278 
